Oscar Health beats on adjusted EPS by a penny, CEO says it will “return to profitability” in 2026
Oscar Health rose in premarket trading after it reported earnings results that edged ahead of Wall Street expectations by a penny.
The company reported a loss per share of $0.53, compared to the $0.54 loss per share analysts polled by FactSet were penciling in. Oscar reported $2.92 billion in revenue, compared to $3.07 billion analysts expected.
Oscar CEO Mark Bertolini said in a statement that the company is “confident in our ability to expand margins and return to profitability in 2026.”
It also reported a medical loss ratio, a key metric that measures how much revenue from premiums is spent on providing care, of 88.5%, a slightly better result than the 88.8% the Street was expecting. Health insurance companies — particularly those that provide government-sponsored plans, like Oscar — have had a tumultuous year amid soaring medical costs.